Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy
- University of Basel, Switzerland
- University of Copenhagen, Denmark
- CNRS, Université Paris Sud, Université Paris-Saclay, France
- ETH Zürich, Switzerland
- Roche Innovation Center Basel, Switzerland
- CNRS, France
- University of Lyon, France
Abstract
Intracellular inclusions rich in alpha-synuclein are a hallmark of several neuropathological diseases including Parkinson's disease (PD). Previously, we reported the structure of alpha-synuclein fibrils (residues 1-121), composed of two protofibrils that are connected via a densely-packed interface formed by residues 50-57 (Guerrero-Ferreira, eLife 218;7:e36402). We here report two new polymorphic atomic structures of alpha-synuclein fibrils termed polymorphs 2a and 2b, at 3.0 Å and 3.4 Å resolution, respectively. These polymorphs show a radically different structure compared to previously reported polymorphs. The new structures have a 10 nm fibril diameter and are composed of two protofilaments which interact via intermolecular salt-bridges between amino acids K45, E57 (polymorph 2a) or E46 (polymorph 2b). The non-amyloid component (NAC) region of alpha-synuclein is fully buried by previously non-described interactions with the N-terminus. A hydrophobic cleft, the location of familial PD mutation sites, and the nature of the protofilament interface now invite to formulate hypotheses about fibril formation, growth and stability.
Data availability
Raw cryo-EM micrographs are available in EMPIAR, entry numbers EMPIAR-10323. The 3D maps are available in the EMDB, entry numbers EMD-10307 (α-Syn polymorph 2a) and EMD-10305 (α-Syn-polymorph 2b). Atomic coordinates are available at the PDB with entry numbers PDB 6SSX (α-Syn polymorph 2a) and PDB 6SST (α-Syn polymorph 2b).
Article and author information
Author details
Ricardo Guerrero-Ferreira
Nicholas MI Taylor
Ana-Andreea Arteni
Funding
Novo Nordisk (NNF14CC0001)
- Nicholas MI Taylor
SERI (17.00038)
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
Fondation Bettencourt Schueller
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
fondation pour la Recherche Medicale (Contract DEQ 20160334896)
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
Fondation Simone et Cino Del Duca of the Institut de France and
- Beat H Meier
- Luc Bousset
EC Joint Program on Neurodegenerative Diseases (TransPathND)
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
FRISBI (ANR-10-INSB-05-01)
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
EC Joint Program on Neurodegenerative Diseases (ANR-17-JPCD-0005-01)
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
EC Joint Program on Neurodegenerative Diseases (ANR-17-JPCD-0002-02)
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
EC Joint Program on Neurodegenerative Diseases (Protest-70)
- Ana-Andreea Arteni
- Beat H Meier
- Luc Bousset
Synapsis Foundation (n/a)
- Ricardo Guerrero-Ferreira
- Henning Stahlberg
Heidi-Seiler Stiftung (n/a)
- Ricardo Guerrero-Ferreira
- Henning Stahlberg
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII3_154461)
- Ricardo Guerrero-Ferreira
- Nicholas MI Taylor
- Henning Stahlberg
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII5_177195)
- Ricardo Guerrero-Ferreira
- Henning Stahlberg
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (20020_178792)
- Ricardo Guerrero-Ferreira
- Henning Stahlberg
Agence Nationale de la Recherche (ANR-12-BS08-0013-01)
- Ronald Melki
- Luc Bousset
LABEX ECOFECT (ANR-11-LABX-0048)
- Anja Böckmann
H2020 (IMPRiND)
- Ana-Andreea Arteni
- Ronald Melki
- Luc Bousset
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2019, Guerrero-Ferreira et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 8,891
- views
-
- 1,321
- downloads
-
- 260
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy
eLife 8:e48907.
https://doi.org/10.7554/eLife.48907
Further reading
-
- Neuroscience
Active inference integrates perception, decision-making, and learning into a united theoretical framework, providing an efficient way to trade off exploration and exploitation by minimizing (expected) free energy. In this study, we asked how the brain represents values and uncertainties (novelty and variability), and resolves these uncertainties under the active inference framework in the exploration-exploitation trade-off. Twenty-five participants performed a contextual two-armed bandit task, with electroencephalogram (EEG) recordings. By comparing the model evidence for active inference and reinforcement learning models of choice behavior, we show that active inference better explains human decision-making under novelty and variability, which entails exploration or information seeking. The EEG sensor-level results show that the activity in the frontal, central, and parietal regions is associated with novelty, while the activity in the frontal and central brain regions is associated with variability. The EEG source-level results indicate that the expected free energy is encoded in the frontal pole and middle frontal gyrus and uncertainties are encoded in different brain regions but with overlap. Our study dissociates the expected free energy and uncertainties in active inference theory and their neural correlates, speaking to the construct validity of active inference in characterizing cognitive processes of human decisions. It provides behavioral and neural evidence of active inference in decision processes and insights into the neural mechanism of human decisions under uncertainties.
-
- Genetics and Genomics
- Neuroscience
The mammalian suprachiasmatic nucleus (SCN), situated in the ventral hypothalamus, directs daily cellular and physiological rhythms across the body. The SCN clockwork is a self-sustaining transcriptional-translational feedback loop (TTFL) that in turn coordinates the expression of clock-controlled genes (CCGs) directing circadian programmes of SCN cellular activity. In the mouse, the transcription factor, ZFHX3 (zinc finger homeobox-3), is necessary for the development of the SCN and influences circadian behaviour in the adult. The molecular mechanisms by which ZFHX3 affects the SCN at transcriptomic and genomic levels are, however, poorly defined. Here, we used chromatin immunoprecipitation sequencing to map the genomic localization of ZFHX3-binding sites in SCN chromatin. To test for function, we then conducted comprehensive RNA sequencing at six distinct times-of-day to compare the SCN transcriptional profiles of control and ZFHX3-conditional null mutants. We show that the genome-wide occupancy of ZFHX3 occurs predominantly around gene transcription start sites, co-localizing with known histone modifications, and preferentially partnering with clock transcription factors (CLOCK, BMAL1) to regulate clock gene(s) transcription. Correspondingly, we show that the conditional loss of ZFHX3 in the adult has a dramatic effect on the SCN transcriptome, including changes in the levels of transcripts encoding elements of numerous neuropeptide neurotransmitter systems while attenuating the daily oscillation of the clock TF Bmal1. Furthermore, various TTFL genes and CCGs exhibited altered circadian expression profiles, consistent with an advanced in daily behavioural rhythms under 12 h light–12 h dark conditions. Together, these findings reveal the extensive genome-wide regulation mediated by ZFHX3 in the central clock that orchestrates daily timekeeping in mammals.
